SELE and neoplasm: A number of newly developed drugs aim to cause this programmed cell death through the disruption of the tumor microenvironment (TME) in order to target the cell–cell and cell–ECM interactions by targeting E-selectin on the supporting cells such as endothelial cells [3,4].